The HLA-A *0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A *0206

Bone Marrow Transplantation

Volumn 40, Issue 2, 2007, Pages 165-174

  Torikai, H ^a,b   Akatsuka, Y ^a   Miyauchi, H ^a   Terakura, S ^c   Onizuka, M ^c   Tsujimura, K ^a   Miyamura, K ^c   Morishima, Y ^a   Kodera, Y ^c   Kuzushima, K ^a   Takahashi, T ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HISTIDINE; HLA A ANTIGEN; HLA A2 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN HA 1; UNCLASSIFIED DRUG; HA 1 ANTIGEN; HA-1 ANTIGEN; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; OLIGOPEPTIDE; PRIMER DNA;

ALLELE; ARTICLE; BINDING AFFINITY; CELL CLONE; CELL LINE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; COHORT ANALYSIS; CYTOTOXICITY; GENETICS; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE RECEPTOR GENE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BASE SEQUENCE; CELL LINE; COHORT STUDIES; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; EPITOPE MAPPING; GENES, T-CELL RECEPTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447292529     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705689     Document Type: Article

References (37)

1. Goulmy E. Human minor histocompatibility antigens. Curr Opin Immunol 1996; 8: 75-81.
2. Simpson E, Roopenian D. Minor histocompatibility antigens. Curr Opin Immunol 1997; 9: 655-661.
3. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054-1057.
4. Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336-2341.
5. Mommaas B, Kamp J, Drijfhout JW, Beekman N, Ossendorp F, Van Veelen P et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 2002; 169: 3131-3136.
6. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476-1480.
7. Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223-3230.
8. Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003; 197: 1489-1500.
9. Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K et al. Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant. Br J Haematol 2004; 124: 629-635.
10. Dolstra H, Fredrix H, Maas F, Coulie PG, Brasseur F, Mensink E et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999; 189: 301-308.
11. Dolstra H, de Rijke B, Fredrix H, Balas A, Maas F, Scherpen F et al. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 2002; 32: 2748-2758.
12. Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T et al. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 2006; 107: 3779-3786.
13. Date Y, Kimura A, Kato H, Sasazuki T. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 1996; 47: 93-101.
14. Fernandez-Vina MA, Falco M, Sun Y, Stastny P. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol 1992; 33 163-173.
15. Parham P, Lawlor DA, Lomen CE, Ennis PD. Diversity and diversification of HLA-A,B,C alleles. J Immunol 1989; 142: 3937-3950.
16. + T cell responses against viral and tumor antigens using T cells as novel target APC. J Immunol Methods 2003; 278: 57-66.
17. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 1988; 85: 227-231.
18. Akatsuka Y, Goldberg TA, Kondo E, Martin EG, Obata Y, Morishima Y et al. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 2002; 59: 502-511.
19. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990; 128: 189-201.
20. Sylvester-Hvid C, Kristensen N, Blicher T, Ferre H, Lauemoller SL, Wolf XA et al. Establishment of a quantitative ELISA capable of determining peptide-MHC class I interaction. Tissue Antigens 2002; 59: 251-258.
21. + T cells. Blood 2003; 101: 1460-1468.
22. Akatsuka Y, Martin EG, Madonik A, Barsoukov AA, Hansen JA. Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition. Tissue Antigens 1999; 53: 122-134.
23. + T cells with helper activity as well as cytotoxic capacity. Gene Ther 2005; 12: 1686-1695.
24. Folch G, Lefranc MP. The human T cell receptor beta variable (TRBV) genes. Exp Clin Immunogenet 2000; 17: 42-54.
25. Sudo T, Kamikawaji N, Kimura A, Date Y, Savoie CJ, Nakashima H et al. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J Immunol 1995; 155: 4749-4756.
26. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290-296.
27. Goulmy E, Pool J, van den Elsen PJ. Interindividual conservation of T-cell receptor beta chain variable regions by minor histocompatibility antigen-specific HLA-A*0201-restricted cytotoxic T-cell clones. Blood 1995; 85: 2478-2481.
28. Verdijk RM, Mutis T, Wilke M, Pool J, Schrama E, Brand A et al. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: Implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping. Hematol J 2002; 3: 271-275.
29. Miyazaki M, Akatsuka Y, Nishida T, Fujii N, Hiraki A, Ikeda K et al. Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clin Immunol 2003; 107: 198-201.
30. Klein CA, Wilke M, Pool J, Vermeulen C, Blokland E, Burghart E et al. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. J Exp Med 2002; 196: 359-368.
31. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742-2747.
32. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 7569-7579.
33. Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 2001; 255: 27-40.
34. Gnjatic S, Atanackovic D, Matsuo M, Jager E, Lee SY, Valmori D et al. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs. J Immunol 2003; 170: 1191-1196.
35. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213-219.
36. Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, Barbui AM, van Egmond HM, Strijbosch MP et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia 2004; 18: 798-808.
37. Bodinier M, Peyrat MA, Tournay C, Davodeau F, Romagne F, Bonneville M et al. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat Med 2000; 6: 707-710.